TUOXIN
Xinxiang · Founded 2005
About TUOXIN
TUOXIN is a high-tech enterprise integrating the R&D, production, and sales of chemical synthesis and biological fermentation of nucleoside pharmaceutical intermediates. They offer nucleoside fermentation technology platforms and biotransformation semi-synthesis technology platforms and products, such as cytosine, 5-fluorocytosine, cytidine, and other pharmaceutical intermediates.
Company Facts
- Founded: 2005
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $8.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2015)
- Ticker: neeq:831508
- Website: tuoxinchem.com
- Phone: 0086-373-6351890
Industries & Categories
Biotechnology, Manufacturing, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tuoxin-2063963 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.